18Fluoro-O-(2) Fluoroethyl-L-tyrosine (FET)

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug Name18Fluoro-O-(2) Fluoroethyl-L-tyrosine (FET)
Drug Alias NameN/A
ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsCushing SyndromePituitary Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsCushing SyndromePituitary Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A